Le marché suisse n’est pas très adapté pour la levée de capitaux de PME
Life sciences. L’intérêt des sociétés suisses biotech/medtech est croissant pour Euronext Paris, selon David Revcolevschi, as...
Publicité
Élections USA
Publicité
Publicité
- ABB LTD N44.89-0.36%
- ALCON N80.30.93%
- RICHEMONT N145.30.35%
- GEBERIT N588.20.41%
- GIVAUDAN N40300.78%
- HOLCIM N94.840.87%
- KUEHNE+NAGEL INT N178.3-2.99%
- LOGITECH N66.881.89%
- LONZA N589.43.19%
- NESTLE N87.590.61%
- NOVARTIS N91.280.19%
- PARTNERS GROUP N11111.14%
- ROCHE GS259.1-0.31%
- SIKA N207.30.49%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N839.80%
- SWISS RE N149.450.2%
- SWISSCOM N5410.19%
- UBS GROUP N25.980.82%
- ZURICH INSURANCE N576.8-1.06%
- ABB LTD N44.89-0.36%
- ALCON N80.30.93%
- RICHEMONT N145.30.35%
- GEBERIT N588.20.41%
- GIVAUDAN N40300.78%
- HOLCIM N94.840.87%
- KUEHNE+NAGEL INT N178.3-2.99%
- LOGITECH N66.881.89%
- LONZA N589.43.19%
- NESTLE N87.590.61%
- NOVARTIS N91.280.19%
- PARTNERS GROUP N11111.14%
- ROCHE GS259.1-0.31%
- SIKA N207.30.49%
- SONOVA HOLDING AG253.50%
- SWISS LIFE HOLDING AG N839.80%
- SWISS RE N149.450.2%
- SWISSCOM N5410.19%
- UBS GROUP N25.980.82%
- ZURICH INSURANCE N576.8-1.06%
